Shantell Laketa Heiber

Array ( [id] => 5800896 [patent_doc_number] => 20020009462 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-24 [patent_title] => 'HERPESVIRUS REPLICATION DEFECTIVE MUTANTS' [patent_app_type] => new [patent_app_number] => 08/903830 [patent_app_country] => US [patent_app_date] => 1997-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 18845 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20020009462.pdf [firstpage_image] =>[orig_patent_app_number] => 08903830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4028349 [patent_doc_number] => 05994115 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'Artificial system for the production of infectious human papillomavirus' [patent_app_type] => 1 [patent_app_number] => 8/898636 [patent_app_country] => US [patent_app_date] => 1997-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 6 [patent_no_of_words] => 6519 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/994/05994115.pdf [firstpage_image] =>[orig_patent_app_number] => 898636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4124105 [patent_doc_number] => 06127175 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-03 [patent_title] => 'Cells for the production of recombinant adenoviruses' [patent_app_type] => 1 [patent_app_number] => 8/875223 [patent_app_country] => US [patent_app_date] => 1997-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 16572 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/127/06127175.pdf [firstpage_image] =>[orig_patent_app_number] => 875223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3920905 [patent_doc_number] => 05876723 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-02 [patent_title] => 'Purified human papillomavirus type 33 (HPV-33) peptides as an immunogenic composition' [patent_app_type] => 1 [patent_app_number] => 8/891801 [patent_app_country] => US [patent_app_date] => 1997-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 34 [patent_no_of_words] => 4857 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/876/05876723.pdf [firstpage_image] =>[orig_patent_app_number] => 891801 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4190692 [patent_doc_number] => 06130091 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-10 [patent_title] => 'Method for obtaining a peptide derived from the respiratory syncytial virus polypeptide and bacterium expressing it' [patent_app_type] => 1 [patent_app_number] => 8/836504 [patent_app_country] => US [patent_app_date] => 1997-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5233 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/130/06130091.pdf [firstpage_image] =>[orig_patent_app_number] => 836504 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4201286 [patent_doc_number] => 06077514 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-20 [patent_title] => 'Attenuated respiratory syncytial virus' [patent_app_type] => 1 [patent_app_number] => 8/882358 [patent_app_country] => US [patent_app_date] => 1997-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11328 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 268 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/077/06077514.pdf [firstpage_image] =>[orig_patent_app_number] => 882358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4353267 [patent_doc_number] => 06174532 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-16 [patent_title] => 'L2 immunogenic peptides of papillomavirus' [patent_app_type] => 1 [patent_app_number] => 8/817548 [patent_app_country] => US [patent_app_date] => 1997-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 7 [patent_no_of_words] => 4310 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/174/06174532.pdf [firstpage_image] =>[orig_patent_app_number] => 817548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3922907 [patent_doc_number] => 05914260 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-22 [patent_title] => 'Fish pancreatic disease virus' [patent_app_type] => 1 [patent_app_number] => 8/854057 [patent_app_country] => US [patent_app_date] => 1997-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 9154 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/914/05914260.pdf [firstpage_image] =>[orig_patent_app_number] => 854057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1252455 [patent_doc_number] => 06669942 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-12-30 [patent_title] => 'Defective adenoviruses including a therapeutic gene and an immunoprotectove gene' [patent_app_type] => B2 [patent_app_number] => 08/817494 [patent_app_country] => US [patent_app_date] => 1997-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9898 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/669/06669942.pdf [firstpage_image] =>[orig_patent_app_number] => 08817494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3996071 [patent_doc_number] => 05922618 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-13 [patent_title] => 'Dye-labeled antibody conjugate and preparation method thereof' [patent_app_type] => 1 [patent_app_number] => 8/831204 [patent_app_country] => US [patent_app_date] => 1997-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3814 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/922/05922618.pdf [firstpage_image] =>[orig_patent_app_number] => 831204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3787738 [patent_doc_number] => 05780090 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-14 [patent_title] => 'Flavored products and a process for their preparation' [patent_app_type] => 1 [patent_app_number] => 8/793890 [patent_app_country] => US [patent_app_date] => 1997-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11842 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/780/05780090.pdf [firstpage_image] =>[orig_patent_app_number] => 793890 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4288890 [patent_doc_number] => 06183753 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-06 [patent_title] => 'Recombinant chimeric virus and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/804372 [patent_app_country] => US [patent_app_date] => 1997-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 30259 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/183/06183753.pdf [firstpage_image] =>[orig_patent_app_number] => 804372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4133745 [patent_doc_number] => 06015565 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-18 [patent_title] => 'Glycoprotein B of the RFHV/KSHV subfamily of herpes viruses' [patent_app_type] => 1 [patent_app_number] => 8/804439 [patent_app_country] => US [patent_app_date] => 1997-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 33 [patent_no_of_words] => 66518 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/015/06015565.pdf [firstpage_image] =>[orig_patent_app_number] => 804439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3934752 [patent_doc_number] => 05981173 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Genital human papillomavirus type 68a (HPV-68a), related to the potentially oncogenic HPV-39' [patent_app_type] => 1 [patent_app_number] => 8/815667 [patent_app_country] => US [patent_app_date] => 1997-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 8 [patent_no_of_words] => 8411 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/981/05981173.pdf [firstpage_image] =>[orig_patent_app_number] => 815667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4094791 [patent_doc_number] => 06048567 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-11 [patent_title] => 'Higher density foamable instant coffee products for preparing cappuccino like beverages' [patent_app_type] => 1 [patent_app_number] => 8/796356 [patent_app_country] => US [patent_app_date] => 1997-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5985 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/048/06048567.pdf [firstpage_image] =>[orig_patent_app_number] => 796356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4063758 [patent_doc_number] => 05895678 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-20 [patent_title] => 'Method for applying materials to substrates' [patent_app_type] => 1 [patent_app_number] => 8/791315 [patent_app_country] => US [patent_app_date] => 1997-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 2768 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/895/05895678.pdf [firstpage_image] =>[orig_patent_app_number] => 791315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4192903 [patent_doc_number] => 06013261 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-11 [patent_title] => 'Recombinant Marek\'s disease virus (MDV) and vaccine' [patent_app_type] => 1 [patent_app_number] => 8/776660 [patent_app_country] => US [patent_app_date] => 1997-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6987 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/013/06013261.pdf [firstpage_image] =>[orig_patent_app_number] => 776660 [rel_patent_id] =>[rel_patent_doc_number] =>)